/
RSS Feed
PAUL NEWTON, Centre for Clinical Vaccinology and Tropical Medicine, Oxford
REFERENCE: Lancet Infect Dis 2006; 6:602-13
No one knows the exact proportion of anti-infective drugs in the developing world which are not genuine, but even a conservative estimate tells us that counterfeit drugs affect millions of people. A review in the Lancet Infectious Diseases has tried to bring together the available data and propose some solutions to the problem, and Derek Thorne found out more from Paul Newton, of the Centre for Clinical Vaccinology and Tropical Medicine in Oxford.
[audio:https://www.audiomedica.com/podcasting/global_health/060918_paul_newton.mp3]
No one knows the exact proportion of anti-infective drugs in the developing world which are not genuine, but even a conservative estimate tells us that counterfeit drugs affect millions of people. A review in the Lancet Infectious Diseases has tried to bring together the available data and propose some solutions to the problem, and Derek Thorne found out more from Paul Newton, of the Centre for Clinical Vaccinology and Tropical Medicine in Oxford.
